Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...
Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.
Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Live Science on MSN
IVF hormones could be delivered with painless 'microneedle' patch someday, early study hints
Scientists are developing a microneedle patch that they hope could someday simplify IVF hormone delivery. They've tested it ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick up the medicine every few weeks. It would be easier for them to be able to ...
A new, implantable, ultrasound-based blood pressure monitoring system represents a promising alternative to conventional tools for continuous, unobtrusive blood pressure measurement. Accurate, ...
Cosentyx (secukinumab) is a prescription drug used to treat certain types of arthritis and other conditions. The drug comes as a liquid solution inside single-use pens, syringes, and vials. It may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results